光学相干断层扫描血管成像在糖尿病性视网膜病变诊疗中的应用

doi:10.3969/j.issn.2095-378X.2017.04.015

摘要/Abstract

摘要： 光学相干断层扫描血管成像(OCTA)是近年来一种新兴的无创眼底血管成像技术,能快速安全精准地获得高分辨率眼底血管图像,为多种眼科疾病的诊疗提供有力证据。本文就OCTA在糖尿病性视网膜病变(DR)的临床诊疗应用进行简要综述,包括其常见的视网膜毛细血管改变及其在抗血管内皮生长因子(VEGF)药物治疗前后的OCTA图像。

关键词: 光学相干断层扫描血管成像, 糖尿病性视网膜病变, 血管内皮生长因子, 视网膜毛细血管

Abstract: Optical coherence tomography angiography (OCTA) is a novel and non-invasive imaging technique that aquires fundus angiographic information with high resolution quickly,safely,and accurately,which strongly supports the diagnosis and treatment of various ocular diseases.This article reviewed the clinical application of OCTA to diabetic retinopathy (DR),including common changes of retinal capillaries and related OCTA images before and after anti-vascular endothelial growth factor (VEGF) medication.

Key words: Optical coherence tomography angiography, Diabetic retinopathy, Vascular endothelial growth factor, Retinal capillary

中图分类号:

R779.6

王桑桑, 荣翱. 光学相干断层扫描血管成像在糖尿病性视网膜病变诊疗中的应用[J]. 外科研究与新技术, 2017, 6(4): 281-285.

WANG Sangsang, RONG Ao. Application of OCTA to diagnosis and treatment of diabetic retinopathy[J]. Surgical Research and New Technique, 2017, 6(4): 281-285.

参考文献

[1] Spaide RF,Klancnik JM,Cooney MJ.Retinal vascular layers imaged by fluorescein angiography and optical coherence tomography angiography[J].JAMA Ophthalmol,2015,133(1):45-50.
[2] Spaide RF,Klancnik JM,Cooney MJ.Retinal vascular layers in macular telangiectasia type 2 imaged by optical coherence tomographic angiography[J].JAMA Ophthalmol,2015,133(1):66-73.
[3] Couturier A,Mane V,Bonnin S,et al.Capillary plexus anomalies in diabetic retinopathy on optical coherence tomography angiography[J].Retina,2015,35(11):2384-2391.
[4] Ryan SJ,Sadda SR,Hinton DR.Retina[M].London:Elsevier Saunders,2013:925-939.
[5] Varma R,Bressler NM,Doan QV,et al.Prevalence of and risk factors for diabetic macular edema in the United States[J].JAMA Ophthalmol,2014,132(11):1334-1340.
[6] Sim DA,Keane PA,Zarranz-Venturaetal J,et al.Predictive factors for the progression of diabetic macular ischemia[J].Am J Ophthalmol,2013,156(4):684-692.
[7] Gill A,Cole ED,Novais EA,et al.Visualization of changes in the foveal avascular zone in both observed and treated diabetic macular edema using optical coherence tomography angiography[J].Int J Retin Vitr,2017,3(1):19.
[8] 董秀芬,钟华.Angio-OCT在眼科疾病临床应用中研究进展[J].眼科新进展,2016,36(7):697-700.
[9] Carlo TED,Romano A,Waheed NK,et al.A review of optical coherence tomography angiography[J].Int J Retin Vitr,2015,1(5):48-50.
[10] Jia Y,TAN O,Okayea J,et al.Split-spectrum amplitude-decorrelation angiography with optical coherence tomography[J].Opt Express,2012,20(4):4710-4725.
[11] Song SJ,Wong TY.Current concepts in diabetic retinopathy[J].Diabetes Metab J,2014,38(6):416-425.
[12] Savastano MC,Lumbroso B,Rispoli M.In vivo characterization of retinal vascularization morphology using optical coherence tomography angiography[J].Retina,2015,35(11):2196-2203.
[13] Jia Y,Bailey ST,Hwang TS,Mcclintic SM,et al.Quantitative optical coherence tomography angiography of vascular abnormalities in the living human eye[J].Proc Natl Acad Sci USA,2015,112(18):2395-2402.
[14] Al-Sheikh M,Akil H,Pfau M,et al.Swept-source OCT angiography imaging of the foveal avascular zone and macular capillary network density in diabetic retinopathy[J].Invest Ophthalmol Vis Sci,2016,57(8):3907-3913.
[15] Takase N,Nozaki M,Kato A,et al.Enlargement of foveal avascular zone in diabetic eyes evaluated by en face optical coherence tomography angiography[J].Retina,2015,35(11):2377-2383.
[16] Freiberg FJ,Pfau M,Wons J,et al.Optical coherence tomography angiography of the foveal avascular zone in diabetic retinopathy[J].Graefes Arch Clin Exp Ophthalmol,2016,254(6):1051-1058.
[17] Mastropasqua R,Toto L,Mastropasqua A,et al.Foveal avascular zone area and parafoveal vessel density measurements in different stages of diabetic retinopathy by optical coherence tomography angiography[J].Int J Ophthalmol,2017,10(10):1545-1551.
[18] 向湘,马红婕,唐仕波.OCTA在DR患者黄斑血流密度观察中的应用[J].国际眼科杂志,2017,17(7):1344-1347.
[19] Ghasemi FK,Iafe NA,Hubschman JP,et al.Optical coherence tomography angiography analysis of the foveal avascular zone and macular vessel density after anti-VEGF therapy in eyes with diabetic macular edema and retinal vein qcclusion[J].Invest Ophthalmol Vis Sci,2017,58(1):30-34.
[20] Lee J,Moon BG,Cho AR,et al.Optical coherence tomography angiography of DME and its association with anti-VEGF treatment response[J].Ophthalmology,2016,123(11):2368-2375.
[21] Lin YT,Chen YC,Peng YT,et al.Evidence-based medicine of screening of diabetic retinopathy among type 2 diabetes:a clinical overview[J].Health,2015,7(7):873-883.
[22] Michalska-Malecka K,Heinke Knudsen A.Optical coherence tomography angiography in patients with diabetic retinopathy treated with anti-VEGF intravitreal injections:case report[J].Medicine,2017,96(45):e8379.
[23] Ishibazawa A,Nagaoka T,Takahashi A,et al.Optical coherence tomography angiography in diabetic retinopathy:a prospective pilot study[J].Am J Ophthalmology,2015,160(1):35-44.
[24] Matsunaga DR,Jack JY,De Koo LO,et al.Optical coherence tomography angiography of diabetic retinopathy in human subjects[J].Ophthalmic Surg Lasers Imaging Retina,2015,46(8):796-805.
[25] Salz DA,de Carlo TE,Adhi M,et al.Select features of diabetic retinopathy on swept-source optical coherence tomographic angiography compared with fluorescein angiography and normal eyes[J].JAMA Ophthalmol,2016,134(6):644-650.
[26] Leicht SF,Kernt M,Neubauer A,et al.Microaneurysm turnover in diabetic retinopathy assessed by automated retmarker DR image analysis-potential role as biomarker of response to ranibizumab treatment[J].Ophthalmologica,2014,231(4):198-203.
[27] Haritoglou C,Kernt M,Neubauer A,et al.Microaneurysm formation rate as a predictive marker for progression to clinically significant macular edema in nonproliferative diabetic retinopathy[J].Retina,2014,34(1):157-164.
[28] Manousaridis K,Talks J.Macular ischaemia:a contraindication for anti-VEGF treatment in retinal vascular disease?[J].Br J Ophthalmol,2012,96(2):179-184.
[29] Campochiaro PA,Bhisitkul RB,Shapiro H,et al.Vascular endothelial growth factor promotes progressive retinal nonperfusion in patients with retinal vein occlusion[J].Ophthalmology,2013,120(4):795-802.
[30] Kubota T,Morita H,Tou N,et al.Histology of fibrovascular membranes of proliferative diabetic retinopathy after intravitreal injection of bevacizumab[J].Retina,2010,30(3):468-472.
[31] Spaide RF,Fujimoto JG,Waheed NK.Image artifacts in optical coherence tomography angiography[J].Retina,2015,35(11):2163-2180.
[32] Suzuma K,Tsuiki E,Matsumoto M,et al.Retro-mode imaging of fibrovascular membrane in proliferative diabetic retinopathy after intravitreal bevacizumab injection[J].Clin Ophthalmol,2011,5(1):897-900.
[33] Choi WJ,Mohler KJ,Potsaid B,et al.Choriocapillaris andchoroidal microvasculature imaging with ultrahigh speed OCT angiography[J].PloS One,2013,8(12):e81499.
[34] Bhutto I,Lutty G.Understanding age-related macular degeneration (AMD):relationshipsbetween the photoreceptor/retinal pigment epithelium/Bruch’s membrane/choriocapillaris complex[J].Mol Aspects Med,2012,33(4):295-317.
[35] Dodo Y,Suzuma K,Ishihara K,et al.Clinical relevance of reduced decorrelation signals in the diabetic inner choroid on optical coherence tomography angiography[J].Sci Rep,2017,7(1):5227.
[36] Dimitrova G,Chihara E,Takahashi H,et al.Quantitative retinal optical coherence tomography angiography in patients with diabetes without diabetic retinopathy[J].Invest Ophthalmol Vis Sci,2017,58(1):190-196.
[37] Hua R,Liu L,Wang X,et al.Imaging evidence of diabetic choroidopathy in vivo:angiographic pathoanatomy and choroidal-enhanced depth imaging[J].PloS One,2013,8(12):e83494.
[38] Melancia D,Vicente A,Cunha JP,et al.Diabetic choroidopathy:a review of the current literature[J].Graefes Arch Clin Exp Ophthalmol,2016,254(8):1453-1461.